FMR CORP 13D/13G Filings for ArriVent BioPharma, Inc. Common Stock (AVBP)

FMR CORP 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-12
09:50 am
Purchase		 2024-11-08 13G ArriVent BioPharma, Inc. Common Stock
AVBP		 FMR CORP 2,119,695
6.311%		 2,119,695increase
(New Position)		 Filing